Zoetis Inc (ZTS) to Issue Dividend Increase – $0.13 Per Share

Zoetis Inc (NYSE:ZTS) declared a quarterly dividend on Tuesday, December 12th, Wall Street Journal reports. Investors of record on Friday, January 19th will be paid a dividend of 0.126 per share on Thursday, March 1st. This represents a $0.50 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date is Thursday, January 18th. This is a boost from Zoetis’s previous quarterly dividend of $0.11.

Zoetis has increased its dividend by an average of 13.4% per year over the last three years and has raised its dividend every year for the last 4 years. Zoetis has a payout ratio of 21.1% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Zoetis to earn $2.72 per share next year, which means the company should continue to be able to cover its $0.50 annual dividend with an expected future payout ratio of 18.4%.

Zoetis (NYSE ZTS) opened at $75.39 on Friday. Zoetis has a 12-month low of $52.00 and a 12-month high of $75.69. The stock has a market cap of $36,740.00, a PE ratio of 39.68, a P/E/G ratio of 1.91 and a beta of 1.06. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Thursday, November 2nd. The company reported $0.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.63 by $0.02. Zoetis had a net margin of 21.97% and a return on equity of 64.54%. The company had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.32 billion. During the same period last year, the company posted $0.52 EPS. Zoetis’s revenue was up 8.5% on a year-over-year basis. equities analysts anticipate that Zoetis will post 2.37 earnings per share for the current year.

A number of research analysts recently issued reports on ZTS shares. BMO Capital Markets reissued a “hold” rating and set a $65.00 price target on shares of Zoetis in a research report on Thursday, November 2nd. Cowen set a $80.00 price objective on shares of Zoetis and gave the company a “buy” rating in a research note on Friday, November 17th. Morgan Stanley upgraded shares of Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 price objective for the company in a research note on Wednesday, November 29th. UBS Group restated a “neutral” rating on shares of Zoetis in a research note on Friday, November 24th. Finally, Citigroup upgraded shares of Zoetis from a “neutral” rating to a “buy” rating and set a $85.00 price objective for the company in a research note on Thursday, January 4th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $71.28.

TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Markets Daily and is the property of of Markets Daily. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2018/01/13/zoetis-inc-zts-to-issue-dividend-increase-0-13-per-share.html.

About Zoetis

Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.

Dividend History for Zoetis (NYSE:ZTS)

Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply